SANTALIS PHARMACEUTICALS
Santalis Pharmaceuticals is manufactures and markets botanical pharmaceuticals using sandalwood oil.
SANTALIS PHARMACEUTICALS
Industry:
Manufacturing Pharmaceutical
Founded:
2010-01-01
Address:
San Antonio, Texas, United States
Country:
United States
Status:
Active
Current Employees Featured
More informations about "Santalis Pharmaceuticals"
Santalis Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical ...
Explore Santalis Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, Drug:East Indian sandalwood oil.See details»
Santalis Pharmaceuticals, Inc. - Corporation Wiki
Santalis Pharmaceuticals, Inc. Overview Santalis Pharmaceuticals, Inc. filed as a Domestic For-Profit Corporation in the State of Texas on Thursday, September 9, 2010 and is approximately โฆSee details»
Santalis Pharmaceuticals - PitchBook
Santalis Pharmaceuticals General Information Description. Developer of botanical-based healthcare products. The company is developing dermatology โฆSee details»
Santalis Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Santalis Pharmaceuticals, Inc. of San Antonio, TX. Get the latest business insights from Dun & Bradstreet.See details»
Santalis Pharmaceuticals Information - RocketReach
US-based Santalis Pharmaceuticals, Inc. is a wholly-owned subsidiary of Quintis Ltd. of Perth, Australia (ASX:QIN). Santalis was formed to develop a range of OTC and prescription โฆSee details»
Santalis Pharmaceuticals - Products, Competitors, Financials, โฆ
Santalis Pharmaceuticals Enrolls First U.S. Subject Into a Phase 2 Clinical Study of Mild to Moderate Atopic Dermatitis May 09, 2017 07:15 AM Eastern Daylight Time SAN ANTONIO--( โฆSee details»
Santalis Pharmaceuticals - LinkedIn
US-based Santalis Pharmaceuticals, Inc. is a wholly-owned subsidiary of Quintis Ltd. of Perth, Australia (ASX:QIN). Santalis was formed to develop a range of OTC and prescription โฆSee details»
Santalis Pharmaceuticals acquired by TFS Corporation - Crunchbase
Jun 18, 2015 Santalis Pharmaceuticals Santalis Pharmaceuticals is manufactures and markets botanical pharmaceuticals using sandalwood oil. Acquiring Organization: TFS Corporation โฆSee details»
Santalis Pharmaceuticals - Contacts, Employees, Board Members, โฆ
Organization. Santalis Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Contacts 2. โฆSee details»
Santalis Pharmaceuticals Management Team | Org Chart
Santalis Pharmaceuticals employs 6 employees. The Santalis Pharmaceuticals management team includes Ian Clements (CBO and Co-Founder), and John Popko (Clinical Project โฆSee details»
Santalis Pharma - Company Profile - Tracxn
Oct 14, 2024 Santalis Pharma - Clinical-stage pharma company developing sandalwood-oil-origin botanical drugs for infections and dermatological diseases. Acquired by Quintis. Raised โฆSee details»
Targeted Technology | Fund I - Santalis Pharmaceuticals, Inc.
Santalis Pharmaceuticals, Inc. is a joint venture with TFS Corporation of Australia (ASX: TFC), the world's leader in sustainable sandalwood oil (EISO) supply. TFS has granted Santalis โฆSee details»
Australiaโs TFS to buy US pharmaceutical firms ViroXis, Santalis
Jun 22, 2015 Australian company TFS Corporation Limited (TFS), a producer of Indian sandalwood oil, is to acquire its U.S.-based pharmaceutical partners ViroXis Corporation and โฆSee details»
Santalis Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. Santalis Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 9. About. โฆSee details»
What is Santalis Pharmaceuticals ? Company Culture, Mission, Values
Santalis Pharmaceuticals . Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. โฆSee details»
Patent Issued for the Use of Sandalwood Oil to Treat Cancers
Apr 27, 2017 According to Dr. Paul Castella, CEO of Santalis Pharmaceuticals, "We're very pleased that the first patent allowed to us in Australia since we became part of Quintis Ltd. in โฆSee details»
Womenโs Health, Endometriosis, and Entrepreneurship
Prior to founding Hera, Somer, spent seven years as the Director of Clinical Operations for Santalis Pharmaceuticals where she built out the clinical program at the company. During her โฆSee details»
Paul Castella - CEO @ Santalis Pharmaceuticals - Crunchbase
Paul Castella has 2 current jobs as CEO at Santalis Pharmaceuticals and Co-founder, Director at ViroXis. ... Santalis Pharmaceuticals CEO Nov 2011. ViroXis Co-founder, Director 2005. โฆSee details»
East Indian sandalwood oil - Drug Targets, Indications, Patents
This trial will be a double-blind, randomized, placebo-controlled, safety, tolerability and efficacy trial of SAN007 (5% East Indian sandalwood oil in a cream formulation) treatment regimen โฆSee details»